Under The Knife

Under The Knife

Under The Knife 7/6/26

A Carlos Problem

Will Carroll's avatar
Will Carroll
Jul 06, 2026
∙ Paid

SHOHEI OHTANI, SP/DH LAD (inflamed shoulder)

Shohei Ohtani was right back in the lineup, which tells you this biceps/shoulder issue isn’t viewed as structurally significant. That’s encouraging, but it also shifts the conversation. His elbow has been the headline for years and the knee has demanded occasional maintenance. The shoulder is different because it affects both versions of Shohei Ohtani at the same time.

When Ohtani was rehabbing his UCL, he could still be one of the best hitters in baseball. The elbow limited one job while leaving the other largely intact. A sore shoulder doesn’t offer that luxury. The shoulder is central to the pitching delivery, but it’s also essential to controlling the barrel through the hitting zone, decelerating the swing, and recovering between games. It’s one anatomical problem shared by two elite athletes who happen to occupy the same body.

The injury is referred to as “biceps soreness”, but remember that the biceps and labrum are anatomically connected. Yes, Ohtani injured in the World Series a couple years ago, but that was on the left, non-throwing, back-shoulder side. I’m calling it a shoulder issue because where the biceps tendon goes up into the shoulder, if I pointed at it, most would call it a shoulder.

The good news is that what I’m hearing from a trusted source is that this is soreness rather than inflammation. That may sound like semantics, but it matters. Soreness suggests workload and recovery. Inflammation often points toward tissue that’s becoming irritated. The treatment plan ends up looking familiar either way: rest, manual therapy, strengthening, recovery work, and careful monitoring. The All-Star break arrives at exactly the right time because it gives the Dodgers several consecutive days without asking Ohtani to be either player.

The Dodgers have always been comfortable managing stars this way. They aren’t interested in winning the award for Most Games Played in July. They’re trying to have the best version of Ohtani available in October.

There’s another benefit if the shoulder needs occasional breathers. Every day Ohtani isn’t occupying the DH spot becomes an opportunity. A veteran gets off his feet. A catcher gets half a day of rest. An outfielder nursing a sore hamstring keeps his bat in the lineup. The Dodgers treat roster flexibility as a competitive advantage and Ohtani’s workload management can actually expand that advantage rather than restrict it. That’s the paradox of having the best player in the world. Sometimes protecting him helps everyone else too.

CARLOS RODON, SP NYY (inflamed elbow)
CARLOS LAGRANGE, RP NYY (sprained shoulder)

The Yankees pitching hasn’t been to plan all year. Gerrit Cole had his long slow start and never overlapped with Max Fried, who’s getting closer to a rehab assignment. Before he gets back, Carlos Rodon is down and this one looks serious. While early reports on the imaging say no damage to the UCL, something is causing “significant inflammation” in Rodon’s pitching elbow. Worse, one of the Yankees top prospects, Carlos Lagrange, hits the MILB IL with a shoulder capsule sprain that’s going to cost him significant time and makes the expected second half bullpen mix very different.

Rodón avoiding another ligament injury is a massive win, but it doesn’t mean the Yankees are out of the woods. Significant inflammation isn’t a diagnosis any more than “back pain” is. It’s the elbow waving a red flag. The PRP injection and shutdown suggest the club believes there’s an irritated structure that simply needs to settle down rather than something that needs to be reconstructed. That’s the optimistic read, and one shared by the early imaging.

The problem is that every time the Yankees have begun to resemble the roster Brian Cashman built, another piece disappears. Cole. Fried. Now Rodon. Luis Gil has been stop-and-start. The rotation has spent more time on paper than on the mound, even with Cam Schlittler emerging as the ace. Instead of augmenting a contender at the deadline, Cashman has been forced to rebuild one in real time.

Lagrange’s injury quietly hurts almost as much. The plan had shifted toward getting his triple-digit fastball to the Bronx as a bullpen weapon for the stretch run. A shoulder capsule sprain takes that option off the board for at least six weeks, and shoulder capsules have a nasty habit of caring very little about optimistic calendars.

That’s why the deadline has changed. A month ago, another reliever and perhaps a bench bat looked like luxuries. Now the Yankees probably need at least one starter capable of taking meaningful innings and multiple bullpen arms. The internal reinforcements keep getting pushed back, forcing Cashman to look outside the organization.

The Yankees are still good enough to make October. They’re just no longer the team anyone imagined in March. This deadline isn’t about putting the finishing touches on a favorite. It’s about rebuilding enough of the foundation that the house is still standing when October arrives. (And no update on Aaron Judge yet either, but as of when I send this, he still hasn’t had a re-imaging on that rib.)

Another episode of Injury Territory is up and I address Paul Skenes there rather than here. Why? There’s no real injury, but a lot of discussion about Skenes’ data. It’s a better format for that. So go watch/listen/subscribe, and please consider subscribing here. It’s monthly and just $5, the lowest I can make it on Substack. You’ll get to see notes and context on 26 different players, just today. That feels like good value.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2026 Will Carroll · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture